Short answer · Medically reviewed summary · Last updated: 2026-04-07
Cryopyrin-associated periodic syndrome (CAPS) is a spectrum of autoinflammatory disorders characterized by recurrent episodes of fever, urticaria-like skin rashes, and systemic inflammation triggered by cold or stress. Symptoms range from mild, intermittent manifestations in Familial Cold Autoinflammatory Syndrome (FCAS) to severe, life-threatening organ involvement in Neonatal-Onset Multisystem Inflammatory Disease (NOMID). What are the primary symptoms of Cryopyrin-associated periodic syndrome? The clinical presentation of Cryopyrin-associated periodic syndrome is driven by the overproduction of interleukin-1 beta (IL-1β).
Cryopyrin-associated periodic syndrome (CAPS) is a spectrum of autoinflammatory disorders characterized by recurrent episodes of fever, urticaria-like skin rashes, and systemic inflammation triggered by cold or stress. Symptoms range from mild, intermittent manifestations in Familial Cold Autoinflammatory Syndrome (FCAS) to severe, life-threatening organ involvement in Neonatal-Onset Multisystem Inflammatory Disease (NOMID).
The clinical presentation of Cryopyrin-associated periodic syndrome is driven by the overproduction of interleukin-1 beta (IL-1β). The most universal symptom across the CAPS spectrum is a non-pruritic, urticaria-like (hives-like) skin rash. This rash is often the first sign of Cryopyrin-associated periodic syndrome and may be exacerbated by cold exposure or physical fatigue. Beyond the skin, patients frequently experience:
Because Cryopyrin-associated periodic syndrome is a spectrum, the severity varies significantly between the three historical classifications. FCAS is typically the mildest form, presenting with episodic symptoms triggered by cold. Muckle-Wells Syndrome (MWS) represents an intermediate severity with chronic urticaria and a higher risk of sensorineural hearing loss. Finally, NOMID (also known as CINCA) is the most severe form of Cryopyrin-associated periodic syndrome, often present from birth and characterized by chronic aseptic meningitis, bony overgrowth, and potential neurological impairment if left untreated.
Early identification of Cryopyrin-associated periodic syndrome is critical to preventing permanent damage. Families should watch for persistent unexplained rashes in infants, failure to thrive, or recurring fevers that do not respond to standard antibiotics. Over time, chronic systemic inflammation can lead to serious complications, including:
You should seek urgent medical care if a patient with Cryopyrin-associated periodic syndrome experiences a sudden change in neurological status, such as severe, persistent headache, confusion, or neck stiffness, which may indicate aseptic meningitis. Additionally, any signs of decreased urine output or significant edema (swelling) should be evaluated immediately as these may indicate kidney involvement related to secondary amyloidosis.
Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.